CD4 and Hypertension: Particularly, the higher immune activation and systemic inflammation biomarkers levels (sST2 and hsCRP) and the low absolute CD4+ T-cell count could promote an increase of the risk of arterial hypertension and diastolic dysfunction in INRs [37].